EndoPAT is another leading technology for the measurement of endothelial function. It quantifies the endothelium-mediated changes in vascular tone, elicited by a 5-minute occlusion of the brachial artery.

Calroy’s William Sotka not only sold EndoPAT to medical offices through the US, he also trained physicians on the clinical use of the technology. Later he trained new sales representatives and distributor groups in the presentation and use of EndoPAT technology.

Bookmark the permalink.